Interaction of bifidobacteria with the gut and their influence in the immune function

Biocell

Volumn 27, Issue 1, 2003, Pages 1-9

  Perdigón, Gabriela ^a   Locascio, Mónica ^a   Medici, Marta ^a   De Ruiz Holgado, Aida Pesce ^a   Oliver, Guillermo ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

Bifidobacteria; Homologous and Heterologous strains; Immune System

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; CONTROLLED STUDY; EPITHELIUM CELL; FECES; FERMENTATION; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; LARGE INTESTINE; MILK; MOUSE; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BACTERIAL ADHESION; BIFIDOBACTERIUM; EPITHELIAL CELLS; FECES; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INTESTINES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; SPECIES SPECIFICITY;

ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS;

EID: 0037788116     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Abdelali H, Cassand P, Saussotte B, Koch-Bocabeille B, Narbonne J (1995). Antimutagenicity of components of dairy products. Mutations Res. 331: 133-141.
2. Bartram H, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E, Kasper H (1994). Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects? Am J Clin Nutr 59: 428-432.
3. Bouhnik Y (1993). Survie et effects chez l'homme des bactéries ingéreés dans les laits fermentés. Lait. 73: 241-247.
4. Eckman L, Kagnoff M, Fierrer J (1995). Intestinal epithelial cells as watchdogs for the natural immune system. Trends Microbiol. 3: 118-120.
5. Elson CH, Zivory J (1996). Oral tolerance: A commentary. In: Essentials of Mucosal Immunology. Kagnoff M. and Kiyono H., Ed. Academic Press, Inc., San Diego, CA. pp. 543-554.
6. Gibson G, Wang X (1994). Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol. 77: 412-420.
7. Gomes AMP, Xavier Malcata F (1999). Bifidobacterium ssp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food Sc. & Techn. 10: 139-157.
8. Gordon J, Hooper V, Bry L, Midtved T, Falk P (1997). Interaction between epithelial cells and bacteria, normal and pathogenic response. Science 276: 965-967.
9. Grill J, Crociani J, Ballongue J (1995a). Effects of bifidobacteria on nitrites and nitrosamines. Lett Appl Microbiol 20: 328-330.
10. Grill J, Maniginot-Dürc C, Schneider F, Ballongue J (1995b). Bifidobacteria and probiotic effect: action of Bifidobacterium species on conjugated bile salts. Curr Microbiol 31: 23-27.
11. Hershberg R, Mayer L (2000). Antigen processing and presentation by intestinal epithelial cells-polarity and complexity. Immunol Today 21: 123-128.
12. Holzapfel W, Haberer P, Geisen R, Bjorkroth J, Schillinger V (2001). Taxonomy and important features of probiotic microorganisms in food and nutrition. American J Clin Nutr 73: 365-373.
13. Kagnoff M (1993). Immunology of the intestinal tract. Gastroenterology 105: 1275-1280.
14. Kagnoff M, Lars E, Yang S, Huang G, Jung H, Reed S, Fierer J (1996). Intestinal epithelial cells: an integral component of the mucosal immune system. In: Essentials of Mucosal Immunology. Kagnoff M., Kiyono H., Ed. Academic Press, Inc, San Diego, California. pp. 63-70.
15. Kimura K, Mc Cartney A, Mc Connell M, Tannock G (1997). Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunologic response of their human host to the predominat strains. App Environ Microbiol 63: 3394-3398.
16. Link-Amster H, Rochat F, Saudan K, Mignot O, Aeschlimann J (1994). Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10: 55-64.
17. Marin M, Lee J, Murtha J, Ustunol Z, Pestka J (1997). Differential cytokine production in clonal macrophage and T cell lines cultured with bifidobacteria. J Dairy Sc 80: 2713-2720.
18. Matzuki T, Watanabe K, Tanaka R, Fukuda M, Ayaizu H (1999). Distribution of bifidobacterial species in human intestinal microflora examined with 165rRNA gene targeted species-specific primers. App Environ Microbiol 65: 4506-4512.
19. Mc Cartney A, Wenzhi W, Tannock G (1996). Molecular analysis of the composition of the bifidobacteria and lactobacilli microflora of humans. App Environ Microbiol 62: 4608-4613.
20. Mestecky J, Mc Ghee J (1987). Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40: 153-245.
21. Misra A, Kuila R (1995). Antimicrobial substances from Bifidobacterium bifidum. Indian J Dairy Sc 48: 612-614.
22. Moreau MC, Gaboriau-Routhiau V (2000). Influence of resident intestinal microflora on the development and functions of the intestinal-associated lymphoid tissue. In: Probiotics 3. Immunomodulation by the gut microflora and probiotics. Fuller R., Perdigón G., Ed. Kluwer Academic Publishers. pp. 69-104.
23. Moore W, Moore L (1995). Intestinal flora of populations that have a high risk of colon cancer. App Environ Microbiol 61: 3202-3207.
24. Neutra M, Kraehenbuhl J (1992). Transepithelial transport and mucosal defense. It the role of M cells. Trends Cell Biol 2: 134-138.
25. Perdigón G, Alvarez S, Gobbato N, De Budeguer M, P De Ruiz Holgado A (1995). Comparative effect of the adjuvant capacity of Lactobacillus casei and LPS on the intestinal secretory antibody response and resistance to Salmonella typhimurium infection in mice. J Agric Immunol 7: 283-294.
26. Perdigón G, Alvarez S, Medina M, Vintiñi E (1999a). Influence of the oral administration of lactic acid bacteria on IgA producing cells associated to bronchus. Int J Immunother Pharmacol 12: 97-102.
27. Perdigón G, Alvarez S, Vintiñi E, Medina M, Medici M (1999b). Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J Dairy Sci 82: 1108-1114.
28. Perdigón G, Medina M, Vintiñi E, Valdez JC (2000). Intestinal pathway of internalisation of lactic acid bacteria and gut mucosal immunostimulation. Int J Immunopath Pharmacol 13: 141-150.
29. Perdigón G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holgado A (1986). Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 53: 104-410.
30. Saint-Marie G (1962). A paraffin embedding technique for studies employing immuno-fluorescence. J Histochem Cytochem 10: 250-256.
31. Schiffrin E, Rochat F, Link-Amster H, Aeschlimann J, Donnet-Hughes A (1995). Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78: 491-497.
32. Seki M, Igarashi M, Fukuda Y, Simamura S, Kawashima T, Ogasa K (1978). The effect of Bifidobacterium cultured milk on the regularity among aged group. Nutrit Food 4: 379-387.
33. Shah N (1997). Bifidobacteria: characteristics and potential for application in fermented milk products. Milchwissenschaft 52: 16-20.
34. Tahri K, Grill J, Schneider H (1997). Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria. Curr Microbiol 34: 79-84.
35. Takahashi T, Nakagawa E, Nara T, Yajima T, Kuwata T (1998). Effect of orally ingested Bifidobacterium longum on the mucosal IgA response to mice dietary antigens. Biosci Biotechnol Biocherfi 62: 10-15.
36. Tannock G (1999). Microecology of lactobacilli and bifidobacteria inhibiting the digestive tract: Essential knowledge for successful probiotic research. In: Probiotics, other Nutritional Factors and Intestinal Microflora. Hanson H., Yolben R. Ed., Nestlé, Nutrition Workshop series, Nestec Ltd Vevey, Lippincott. Raven Publishers. Philadelpia. pp. 17-28.
37. Umesaki Y, Okada Y, Matsumoto S, Inaoka A, Setoyana H (1996). Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC Class II molecules and fucosyl asialo GM1 glycolipids on the small intestine epithelial cells in the ex-germ free mouse. Microbiol Immunol 39: 555-562.
38. Yasui H, Nagaoka N, Mike A, Hayakawa K, Ohwaki M (1992). Detection of Bifidobacterium strains that induce large quantities of IgA. Microbiol Ecol in Health Dis 5: 155-162.
39. Yasui H, Ohwaki M (1991). Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J Dairy Sci 74: 1187-1195.
40. Yildirim Z, Johnson M (1998). Characterization and antimicrobial spectrum of Bifidocin B a bacteriocin produced by Bifidobacterium bifidum NCFB 1454. J Food Prot 61: 47-51.
41. Zavaglia A, Kociukinski G, Perez P, de Antoni G (1998). Isolation and characterization of Bifidobacterium strains for probiotics formulation. J Food Prot 61: 865-873.